This trial assesses the effectiveness of a procedure to treat chronic rhinitis by comparing patient symptoms, airflow and cytokines before and after.
- Chronic Rhinitis
2 Primary · 2 Secondary · Reporting Duration: Baseline,12 weeks post intervention
Awards & Highlights
1 Treatment Group
Radiofrequency ablation (RFA)
1 of 1
36 Total Participants · 1 Treatment Group
Primary Treatment: Radiofrequency ablation (RFA) · No Placebo Group · N/A
Who is running the clinical trial?
Age 18 - 80 · All Participants · 2 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is this trial still recruiting participants?
"Based on the information found on clinicaltrials.gov, this particular study is no longer enrolling patients as it was last edited over a month ago. However, an array of 66 other trials are presently recruiting across various medical centres." - Anonymous Online Contributor
Are there any elderly participants in this experimentation?
"Those between 18 and 65 years old are eligible to apply for this clinical trial. However, there are 24 trials available for those younger than 18 and 45 studies targeting patients over the age of 65." - Anonymous Online Contributor
Is there still an opportunity to enroll in this clinical experiment?
"This clinical study requires 36 individuals suffering from rhinitis between 18 and 65. To be eligible, hopefuls must have had symptoms of chronic rhinitis for at least 6 months (runny nose, congestion, post-nasal drip), attempted medical management with no effect lasting 4 weeks or more, a rTNSS score ≥6 inclusive of >=2 in regards to runny nose and 1+ concerning nasal blockage." - Anonymous Online Contributor